The influence of dapagliflozin on diabetic ocular complications: An observational cohort study
Dapagliflozin was associated with a significantly lower incidence of DR, OAG, or visual loss in newly diagnosed T2DM patients within five years, suggesting its potential benefit in preventing ocular complications.
Authors
- Jo-Hsin Chen
- Fei-Hung Hung (ORCID: https://orcid.org/0000-0001-9453-916X)
- Jong‐Shiuan Yeh (ORCID: https://orcid.org/0000-0002-2838-6596)
- Shu-Fen Liao
- Yuting Wang (ORCID: https://orcid.org/0000-0001-6176-2381)
- Jinhua Chen
- Chun-Mei Hsueh
- Gregory Y. H. Lip
Institutions
- University of Liverpool (GB)
- Taipei Medical University Hospital (TW)
- Liverpool Heart and Chest Hospital (GB)
- Wan Fang Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- European Journal of Pharmaceutical Sciences
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.ejps.2025.107382
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00